◆ 会议时间:2024年10月26-28日
◆ 会议地点:德国 科隆/Keulen, Germany
◆ 会议简介:
2024年霍奇金淋巴瘤国际研讨会(ISHL13)将于2024年10月26-28日在德国科隆举行。国际霍奇金淋巴瘤研讨会(ISHL)是由德国霍奇金研究小组(GHSG)组织的世界上最大的霍奇金淋巴瘤国际跨学科会议,自1986年起每三年举行一次,会议为医生、科学家和其他国内外专家提供了一个交流平台,以便将最新的研究成果从研究和临床实践宣转化为以实践为导向的治疗方法。本次研讨会旨在全面介绍霍奇金淋巴瘤的研究、诊断和治疗的最新进展。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com).
International Symposium on Hodgkin Lymphoma (ISHL13)
Date:
October 26 - 28, 2024
Venue:
Gürzenich Hall Conference Center
Cologne, Germany
The International Symposium on Hodgkin Lymphoma (ISHL13) will take place in the Gürzenich Hall Conference Center in Cologne, Germany, from October 26 to 28, 2024.
ISHL13 will provide a comprehensive overview of the latest advances in biology, translational and clinical research, diagnostics and treatment of Hodgkin Lymphoma.
注册费:
Ticket offers (in-person)
Early Registration
- Fee: 400.00€
- Deadline: July 15, 2024
Full Registration
- Fee: 500.00€
- Deadline: October 20, 2024
Onsite Registration
- Fee: 575.00€
- Deadline: October 24, 2024
Student Registration
- Fee: 100.00€
- Deadline: October 24, 2024
- Requirement:
-
- A letter confirming your student status will be required from your head of department. Please send this by mail (info@tca-hanke.de) or fax (+49 (0) 2102-964829)
Allied Health Professional
- Fee: 100.00€
- Deadline: October 24, 2024
- Requirement:
-
- A letter confirming your Allied Health Professional status will be required from your head of department. Please send this by mail (info@tca-hanke.de) or fax (+49 (0) 2102-964829)
GHSG Member
- Fee: 280.00€
- Deadline: October 24, 2024
- Requirement:
-
- A letter to identify you as GHSG member will be required. Please send this by mail (info@tca-hanke.de) or fax (+49 (0) 2102-964829)
Young Doctor (age below 35)
- Fee: 330.00€
- Deadline: October 24, 2024
- Requirement:
A copy of your passport confirming your age of max 35 years is required. Please send this by mail (info@tca-hanke.de) or fax (+49 (0) 2102-964829)
Abstract Presenter
- Fee: 400.00€
- Deadline: October 24, 2024
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|